Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a feasibility study of the Nucleus 24 ABI in children without NF2. It will be conducted as a repeated-measures, single subject experiment in order to accommodate the known variability in cochlear implant clinical results. Data obtained in the course of this study will be compared with the existing published outcome data from children with normal hearing and with cochlear implants (CIs). These comparisons may provide additional useful information about the progress of ABI subjects' performance over time. Also, this may allow the results of the current study to be utilized to design future pivotal studies of the device in the pediatric population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 21
Healthy Volunteers: f
View:

⁃ Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years)

⁃ • Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both:

• MRI +/- CT evidence of one of the following:

‣ Cochlear nerve deficiency

⁃ Cochlear aplasia or severe hypoplasia

⁃ Severe inner ear malformation

⁃ Post-meningitis ossification

• When a cochlea is present or patent, lack of significant benefit from CI despite consistent use (\>6 mo.)

‣ No or limited speech perception ability (limited to pattern perception on closed set testing materials using the CI)

⁃ Lack of progress in auditory skills development

⁃ Group 2: Post-linguistic hearing loss (\<21 yrs. of age)

• Post-linguistic hearing loss (\<21 yrs. of age) with:

‣ Loss or lack of benefit from appropriate CI without the possibility for revision or contralateral implantation. Examples might include:

• Post-meningitis ossification

∙ Bilateral temporal bone fractures with cochlear nerve avulsion

∙ Failed revision CI without benefit

⁃ Previously developed open set speech perception and auditory-oral language skills

• No medical contraindications

• Willing to receive the appropriate meningitis vaccinations

• No or limited cognitive/developmental delays.

• Strong family support

• Reasonable expectations from parents/guardians including a thorough understanding:

‣ of potential benefits and limitations of ABI

⁃ of parental role in rehabilitation

⁃ that the child may not develop spoken language as a primary communication mode or even sufficient spoken language to make significant academic progress in an aural/oral environment

• Involvement in a rehabilitation program that emphasizes development of auditory skills with or without the use of supplementary visual communication.

• Able to comply with study requirements including travel to investigation sites.

• Informed consent for the procedure from the child's parents/legal guardian.

Locations
United States
New York
NYU Cochlear Implant Center
RECRUITING
New York
Contact Information
Primary
William Shapiro
William.Shapiro@nyulangone.org
212-263-3311
Backup
Ashley Feng
Ashley.Feng@nyulangone.org
Time Frame
Start Date: 2014-05
Estimated Completion Date: 2030-05
Participants
Target number of participants: 20
Treatments
Experimental: Pre-lingual Deafness
Surgical implantation of the Nucleus ABI541 Auditory Brainstem Implant in prelingiustically deaf children ages 18 months - 5 years
Experimental: Post-Lingual Deafness
Surgical implantation of the Nucleus ABI541 Auditory Brainstem Implant in postlinguistically deaf children \< 21 years of age
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov